Literature DB >> 7215387

Brain uptake of 11C-methionine in phenylketonuria.

D Comar, J M Saudubray, A Duthilleul, J Delforge, M Maziere, G Berger, C Charpentier, A Todd-Pokropek.   

Abstract

The brain uptake of 11C-methionine was studied in 26 children with classical phenylketonuria; one adult was used as a control. Labelled methionine uptake in brain was first measured during a low phenylalanine diet and again one week later after a load of phenylalanine. Ten children aged 1 to 30 months were studied twice at intervals of several months. In children having a phenylalaninemia less than or equal to 0.3 mumoles . ml-1, a decrease in methionine brain uptake was observed with increasing age, with the largest change occurring during the first year of life. After the phenylalanine load, a mean increase in phenylalaninemia by a factor of ten was accompanied by a mean decrease in brain methionine uptake by a factor of two while blood methionine remained unchanged. Brain activity curves increased with time for children younger than one year and having phenylalaninemia less than 0.6 mumoles . ml-1. After the age of 2 most patients had a decreasing curve regardless of the blood phenylalanine level. This study indicates that 11C-methionine brain uptake may be taken as an index of blood barrier permeability to essential amino acids, and of brain maturation. The results obtained suggest that an increase in phenylalaninemia to levels greater than 0.6 mumole . ml-1 induces a modification in brain uptake of amino acids, primarily during the first two years of life.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7215387     DOI: 10.1007/bf00441705

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Experimentally induced and natural recovery from the effects of phenylalanine on brain protein synthesis.

Authors:  J V Hughes; T C Johnson
Journal:  Biochim Biophys Acta       Date:  1978-02-16

2.  Facilitated transport of amino acids through the blood-brain barrier of the dog studied in a single capillary circulation.

Authors:  D L Yudilevich; N De Rose; F V Sepúlveda
Journal:  Brain Res       Date:  1972-09-29       Impact factor: 3.252

3.  Brain uptake of selenomethionine Se 75. II. Reduced brain uptake of selenomethionine Se 75 in phenylketonuria.

Authors:  W H Oldendorf; B W Sisson; A Silverstein
Journal:  Arch Neurol       Date:  1971-06

4.  Cognitive development and dietary therapy in phenylketonuric children.

Authors:  J Dobson; R Koch; M Williamson; R Spector; W Frankenburg; M O'Flynn; R Warner; F Hudson
Journal:  N Engl J Med       Date:  1968-05-23       Impact factor: 91.245

5.  An approach to management of phenylketonuria.

Authors:  R Koch; K N Shaw; P B Acosta; K Fishler; G Schaeffler; E Wenz; A Wohlers
Journal:  J Pediatr       Date:  1970-06       Impact factor: 4.406

6.  Hyperphenylalaninemia: the effect of cerebral amino acid levels during development.

Authors:  J A Lowden; M A LaRamée
Journal:  Can J Biochem       Date:  1969-09

7.  Hyperphenylalanaemia and the exchange of tyrosine in adult rat brain.

Authors:  O F Lindroos; S S Oja
Journal:  Exp Brain Res       Date:  1971       Impact factor: 1.972

8.  Labelling and metabolism of methionine-methyl-11 C.

Authors:  D Comar; J Cartron; M Maziere; C Marazano
Journal:  Eur J Nucl Med       Date:  1976

9.  Results of treatment and termination of the diet in phenylketonuria (PKU).

Authors:  E S Kang; N D Sollee; P S Gerald
Journal:  Pediatrics       Date:  1970-12       Impact factor: 7.124

10.  Intellectual assessment of 111 four-year-old children with phenylketonuria.

Authors:  J C Dobson; M L Williamson; C Azen; R Koch
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

View more
  3 in total

1.  Cerebral protein synthesis in a genetic mouse model of phenylketonuria.

Authors:  C B Smith; J Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.

Authors:  M Wajner; D M Coelho; A G Barschak; P R Araújo; R F Pires; F L Lulhier; C R Vargas
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

3.  Use of acute hyperphenylalaninemia in rhesus monkeys to examine sensitivity and stability of the L-[1-11C]leucine method for measurement of regional rates of cerebral protein synthesis with PET.

Authors:  Carolyn B Smith; Kathleen C Schmidt; Shrinivas Bishu; Michael A Channing; Jeff Bacon; Thomas V Burlin; Mei Qin; Zhong-Hua Liu; Zengyan Xia; Tianjiang Huang; Bee-Kee Vuong; Peter Herscovitch
Journal:  J Cereb Blood Flow Metab       Date:  2008-04-23       Impact factor: 6.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.